S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00041067 Information provided by Southwest Oncology Group

First Received: July 8, 2002 Last Updated: July 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Kash J, Barlow WE, Albain KS, et al.: Phase II Southwest Oncology Group study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer. [Abstract] J Clin Oncol 26 (Suppl 15): A-1033, 2008.